Arlo N. McGinn, Ph.D. - Publications
Affiliations: | 2013 | Pharmacology and Toxicology | University of Utah, Salt Lake City, UT |
Area:
Pharmacy, Pharmacology, GeneticsYear | Citation | Score | |||
---|---|---|---|---|---|
2013 | Lee Y, McGinn AN, Olsen CD, Nam K, Lee M, Shin SK, Kim SW. Human erythropoietin gene delivery for cardiac remodeling of myocardial infarction in rats. Journal of Controlled Release : Official Journal of the Controlled Release Society. 171: 24-32. PMID 23806842 DOI: 10.1016/J.Jconrel.2013.06.022 | 0.397 | |||
2013 | Won YW, McGinn AN, Lee M, Nam K, Bull DA, Kim SW. Post-translational regulation of a hypoxia-responsive VEGF plasmid for the treatment of myocardial ischemia. Biomaterials. 34: 6229-38. PMID 23714244 DOI: 10.1016/J.Biomaterials.2013.04.061 | 0.372 | |||
2013 | Won YW, McGinn AN, Lee M, Bull DA, Kim SW. Targeted gene delivery to ischemic myocardium by homing peptide-guided polymeric carrier. Molecular Pharmaceutics. 10: 378-85. PMID 23214982 DOI: 10.1021/Mp300500Y | 0.403 | |||
2011 | McGinn AN, Nam HY, Ou M, Hu N, Straub CM, Yockman JW, Bull DA, Kim SW. Bioreducible polymer-transfected skeletal myoblasts for VEGF delivery to acutely ischemic myocardium. Biomaterials. 32: 942-9. PMID 20970850 DOI: 10.1016/J.Biomaterials.2010.09.061 | 0.391 | |||
2010 | Nam HY, McGinn A, Kim PH, Kim SW, Bull DA. Primary cardiomyocyte-targeted bioreducible polymer for efficient gene delivery to the myocardium. Biomaterials. 31: 8081-7. PMID 20674007 DOI: 10.1016/J.Biomaterials.2010.07.025 | 0.331 | |||
Show low-probability matches. |